Illumina (ILMN) Competitors $131.68 -3.32 (-2.46%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ILMN vs. PKI, AVTR, A, MTD, WAT, TECH, CRL, BIO, BRKR, and PACBShould you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Revvity (PKI), Avantor (AVTR), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), and Pacific Biosciences of California (PACB). Illumina vs. Revvity Avantor Agilent Technologies Mettler-Toledo International Waters Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Revvity (NYSE:PKI) and Illumina (NASDAQ:ILMN) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, community ranking, profitability, institutional ownership, risk, analyst recommendations and valuation. Does the media prefer PKI or ILMN? In the previous week, Illumina had 17 more articles in the media than Revvity. MarketBeat recorded 17 mentions for Illumina and 0 mentions for Revvity. Illumina's average media sentiment score of 1.06 beat Revvity's score of 0.73 indicating that Illumina is being referred to more favorably in the news media. Company Overall Sentiment Revvity Positive Illumina Positive Do institutionals and insiders believe in PKI or ILMN? 85.2% of Revvity shares are owned by institutional investors. Comparatively, 89.4% of Illumina shares are owned by institutional investors. 0.5% of Revvity shares are owned by insiders. Comparatively, 0.2% of Illumina shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is PKI or ILMN more profitable? Revvity has a net margin of 28.94% compared to Illumina's net margin of -36.10%. Revvity's return on equity of 11.17% beat Illumina's return on equity.Company Net Margins Return on Equity Return on Assets Revvity28.94% 11.17% 5.83% Illumina -36.10%7.29%3.40% Does the MarketBeat Community believe in PKI or ILMN? Illumina received 607 more outperform votes than Revvity when rated by MarketBeat users. Likewise, 65.74% of users gave Illumina an outperform vote while only 58.69% of users gave Revvity an outperform vote. CompanyUnderperformOutperformRevvityOutperform Votes50058.69% Underperform Votes35241.31% IlluminaOutperform Votes110765.74% Underperform Votes57734.26% Which has stronger valuation and earnings, PKI or ILMN? Revvity has higher earnings, but lower revenue than Illumina. Illumina is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRevvity$3.31B0.00$569.18M$7.68N/AIllumina$4.50B4.64-$1.16B-$9.96-13.22 Do analysts recommend PKI or ILMN? Illumina has a consensus target price of $164.00, suggesting a potential upside of 24.54%. Given Illumina's stronger consensus rating and higher probable upside, analysts plainly believe Illumina is more favorable than Revvity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Revvity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Illumina 1 Sell rating(s) 8 Hold rating(s) 13 Buy rating(s) 2 Strong Buy rating(s) 2.67 Which has more risk and volatility, PKI or ILMN? Revvity has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Comparatively, Illumina has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500. SummaryIllumina beats Revvity on 11 of the 18 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ILMN vs. The Competition Export to ExcelMetricIlluminaAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.88B$5.07B$5.03B$8.81BDividend YieldN/A0.46%5.16%4.06%P/E Ratio-13.2223.87135.4117.82Price / Sales4.644.391,160.9774.56Price / Cash37.6940.7033.5332.53Price / Book3.642.084.674.68Net Income-$1.16B$515,312.50$119.07M$226.08M7 Day Performance-7.42%-5.56%-1.83%-1.04%1 Month Performance-9.32%-8.12%-3.60%1.04%1 Year Performance37.21%-17.04%31.66%26.28% Illumina Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ILMNIllumina4.5833 of 5 stars$131.68-2.5%$164.00+24.5%+34.9%$21.41B$4.50B-13.229,300Positive NewsPKIRevvity3.9421 of 5 starsN/AN/AN/A$14.57B$3.31B15.0116,700Analyst ForecastAVTRAvantor4.9762 of 5 stars$20.14+2.1%$27.57+36.9%+3.6%$13.71B$6.97B43.7814,500Analyst RevisionAAgilent Technologies4.3995 of 5 stars$128.57+2.3%$144.36+12.3%+12.8%$36.94B$6.83B26.6718,100Upcoming EarningsNews CoveragePositive NewsMTDMettler-Toledo International4.1104 of 5 stars$1,166.90+0.5%$1,338.75+14.7%+11.1%$24.49B$3.79B31.4617,300Positive NewsWATWaters4.1245 of 5 stars$357.69+3.8%$365.85+2.3%+37.0%$20.47B$2.96B34.137,900TECHBio-Techne4.8558 of 5 stars$68.72+3.5%$81.78+19.0%+8.1%$10.55B$1.16B73.113,100CRLCharles River Laboratories International4.8024 of 5 stars$187.90+1.0%$214.38+14.1%-1.4%$9.52B$4.13B23.5221,800Analyst DowngradeBIOBio-Rad Laboratories4.7149 of 5 stars$323.69+0.9%$391.80+21.0%+6.3%$9.06B$2.58B-11.848,030Positive NewsBRKRBruker4.9986 of 5 stars$53.37+10.6%$79.36+48.7%-12.9%$8.09B$2.96B25.669,707Dividend AnnouncementInsider TradeGap UpHigh Trading VolumePACBPacific Biosciences of California1.5162 of 5 stars$1.72flat$3.63+110.8%-80.0%$471.05M$200.52M0.00730Analyst Revision Related Companies and Tools Related Companies Revvity Alternatives Avantor Alternatives Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ILMN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.